Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 25-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 28)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
24-Apr-14Pechala's ReportsLubomir PechalaPROTALIX BIOTHERAPEUTICS INC (PLX) - REPORT FOR ACTIVE TRADERS1$25  View Abstract
24-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49  View Abstract
24-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Protalix Biotherapeutics Inc42$75  View Abstract
24-Apr-14New Constructs, LLCN/APLX: Due Diligence Review: Forensic Earnings and Valuation5$25  View Abstract
23-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - PROTALIX BIOTHERAPEUTICS INC (PLX-A)11$25  View Abstract
21-Apr-14GlobalDataGlobalDataProtalix BioTherapeutics, Inc. (PLX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile24$250  View Abstract
19-Apr-14Reuters Investment ProfileN/APrzetworstwo Tworzyw Sztucznych Plast-Box SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
19-Apr-14Reuters Investment ProfileN/AProtalix Biotherapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
19-Apr-14Pechala's ReportsFrantisek PechalaPROTALIX BIOTHERAPEUTICS INC (PLX) 12-months forecast1$15  View Abstract
18-Apr-14Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of PROTALIX BIOTHERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20  View Abstract
Next 18

Independent Reports (Showing 1 to 10 of 28)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
24-Apr-14Pechala's ReportsLubomir PechalaPROTALIX BIOTHERAPEUTICS INC (PLX) - REPORT FOR ACTIVE TRADERS1$25View Abstract
24-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49View Abstract
24-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Protalix Biotherapeutics Inc42$75View Abstract
24-Apr-14New Constructs, LLCN/APLX: Due Diligence Review: Forensic Earnings and Valuation5$25View Abstract
23-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - PROTALIX BIOTHERAPEUTICS INC (PLX-A)11$25View Abstract
21-Apr-14GlobalDataGlobalDataProtalix BioTherapeutics, Inc. (PLX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile24$250View Abstract
19-Apr-14Reuters Investment ProfileN/APrzetworstwo Tworzyw Sztucznych Plast-Box SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
19-Apr-14Reuters Investment ProfileN/AProtalix Biotherapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
19-Apr-14Pechala's ReportsFrantisek PechalaPROTALIX BIOTHERAPEUTICS INC (PLX) 12-months forecast1$15View Abstract
18-Apr-14Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of PROTALIX BIOTHERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20View Abstract
Next 18

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.